Magnetic Resonance Imaging to Investigate Silent Strokes During Neck and Skull Angioplasty

Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
Overall Status
Completed
CT.gov ID
NCT00015717
Collaborator
(none)
24
1
35
0.7

Study Details

Study Description

Brief Summary

This study will use magnetic resonance imaging (MRI) to determine if silent strokes occur during angioplasty of the blood vessels in the neck or skull. Neck and skull angioplasties are relatively new procedures whose possible complications are still under investigation.

Patients 18 years of age or older who are admitted to Suburban Hospital in Bethesda, Maryland, for angioplasty of one or more of the blood vessels in the neck or skull may participate in this study. Participants must be able to undergo a brain MRI. Within 24 hours before their angioplasty, patients will provide a medical history and have a physical examination and brain MRI. The physical examination and MRI will be repeated within 24 hours after the angioplasty.

MRI is a diagnostic test that uses a magnetic field and radio waves to show structural and chemical changes in tissues. This technique is more sensitive than X-rays in detecting some changes that occur in diseases of the brain. For the procedure, the patient lies on a table that slides into a metal cylinder (the scanner). The confined space may produce anxiety in some patients, and patients can talk to the technician at all times during the procedure. Earplugs are provided to muffle loud knocking and pulsing noises that occur while the scanner is taking pictures. During the study, the contrast material gadolinium may be injected into an arm vein. Gadolinium "brightens" the pictures, producing better images of brain blood flow.

Patients will be contacted by telephone 30 days after the procedure to follow how they are doing and learn whether any complications resulted from the angioplasty.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Recently cervico-cranial angioplasty and stenting (CCAS) has been introduced as alternative treatment for occlusive disease of the extracranial and the intracranial vessels. Temporary or permanent clinically detectable neurological deficits occur in up to 13% of all patients undergoing CASS and are usually related to distal embolization or hemodynamic insufficiency. Silent cerebral micro-emboli are known to occur in patients undergoing carotid endarterectomy and angioplasty but are believed to be of little clinical significance. Distal embolization may be a technical concern when performing CCAS and could cause silent cerebral ischemia. High resolution diffusion-weighted MRI may detect silent hyperacute ischemic lesions in patients undergoing CCAS and examination by a stroke neurologist may detect clinical deficits otherwise unrecognized.

    Study Design

    Study Type:
    Observational
    Official Title:
    Silent Cerebral Ischemia After Cervico-Cranial Angioplasty Detected by Diffusion-Weighted MRI
    Study Start Date :
    Apr 1, 2001
    Study Completion Date :
    Mar 1, 2004

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      INCLUSION CRITERIA:

      Men and women age 18 years or older admitted for angioplasty with or without stenting of any intra or extra-cranial vessel.

      EXCLUSION CRITERIA:

      Any MRI contraindication (insulin pump, aneurysm clips, implanted neural stimulator, cardiac pacemaker or defibrillator, cochlear implant, metal shrapnel or bullet)

      Patients with hyperperfusion syndrome following the angioplasty.

      Patients with cardiovascular or respiratory instability.

      Patients with severe peri-procedural stroke at risk for herniation.

      Confused or encephalopathic patients who are unable to cooperate.

      Pregnant women.

      Lactating women

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland United States 20892

      Sponsors and Collaborators

      • National Institute of Neurological Disorders and Stroke (NINDS)

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00015717
      Other Study ID Numbers:
      • 010146
      • 01-N-0146
      First Posted:
      May 3, 2001
      Last Update Posted:
      Mar 4, 2008
      Last Verified:
      Mar 1, 2004

      Study Results

      No Results Posted as of Mar 4, 2008